BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Rosiglitazone
,
rs2476601
,
NEUROG3
,
T cell differentiation
,
Leukemia
,
Breast
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
APOA5;jsessionid=1031076DBADAA62369CA7472AD6480E3
(gene)
Summary
General Info
Body Atlas
Most Correlated Tissues
Liver
Fetal liver
Transverse colon
Ascending colon
Stomach cardiac
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Loading...
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
Loading...
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
Loading...
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Loading...
Explore Curated Studies Results
Literature
Most Relevant Literature
Hypertriglyceridemia in Apoa5-/- mice results from reduced amounts of lipoprotein lipase in the capi…
Apolipoprotein A5 controls fructose-induced metabolic dysregulation in mice.
Carboxyl-terminal sequences in APOA5 are important for suppressing ANGPTL3/8 activity.
ApoA5 knockdown improves whole-body insulin sensitivity in high-fat-fed mice by reducing ectopic lip…
The pathogenic mutations of APOA5 in Chinese patients with hyperlipidemic acute pancreatitis.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
There were no clinical trials for APOA5;jsessionid=1031076DBADAA62369CA7472AD6480E3
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ